AstraZeneca (AZ) vaccine. Photo by Yonhap News

AstraZeneca (AZ) vaccine. Photo by Yonhap News

View original image


[Asia Economy Reporter Hanah Na] A case of death after reporting an adverse reaction of 'fever' following vaccination with the AstraZeneca (AZ) vaccine has been reported in South Korea, prompting health authorities to investigate the causal relationship with the vaccination.


The COVID-19 Vaccination Response Promotion Team (Promotion Team) announced on the 14th that a vaccinated individual who reported fever symptoms after receiving the AstraZeneca (AZ) vaccine died on the 13th. The Promotion Team stated, "This case was reported as a suspected adverse reaction after vaccination, but causality has not been confirmed," and explained, "The government conducts epidemiological investigations to assess causality only for severe cases such as death or anaphylaxis."


Specific information about the deceased, such as age, vaccination date and time, time elapsed until death after vaccination, actions taken after reporting adverse reactions, and presence of underlying diseases, has not yet been disclosed. The Promotion Team plans to release information related to the deceased in the afternoon.


Regarding the eight death cases for which the first investigation has been completed, the Promotion Team stated, "It was tentatively judged that it is difficult to recognize causality between adverse reactions after vaccination and death," and announced that the results of epidemiological investigations for other reported cases will be disclosed on the 15th.



So far, a total of 16 cases of death have been reported after receiving COVID-19 vaccines in South Korea.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing